These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2730288)

  • 1. Cytotoxic estrogens: anilin mustard linked 1,1,2-triphenylbut-1-enes with mammary tumor inhibiting activity.
    Schneider MR; Schuderer ML
    Arch Pharm (Weinheim); 1989 Jan; 322(1):59-62. PubMed ID: 2730288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chlorocarbamate-mustard-linked 1,1,2-triphenylbut-1-enes with a selective antitumor activity on mammary tumors containing estrogen receptors.
    Schneider MR; Schuderer ML
    J Cancer Res Clin Oncol; 1988; 114(6):583-7. PubMed ID: 3204105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1-[4-(N,N-bis-beta-chloroethylcarbamoyloxy)-phenyl]-1,2-bis- (hydroxyphenyl)-but-1-enes: drugs specifically targeted against estrogen receptor positive mammary tumors.
    Schneider MR; Schuderer ML
    Arch Pharm (Weinheim); 1990 Apr; 323(4):215-9. PubMed ID: 2360864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1,1,2-triphenylbut-1-enes: relationship between structure, estradiol receptor affinity, and mammary tumor inhibiting properties.
    Schneider MR; von Angerer E; Schönenberger H; Michel RT; Fortmeyer HP
    J Med Chem; 1982 Sep; 25(9):1070-7. PubMed ID: 6813499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetoxy substituted 1,1,2-triphenylbut-1-enes: estrogenic, antiestrogenic and mammary tumor inhibiting activity.
    Schneider MR
    J Cancer Res Clin Oncol; 1986; 112(2):119-24. PubMed ID: 3771620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acetoxy-substituted 1,1,2-triphenylbut-1-enes with antiestrogenic and mammary tumor inhibiting properties.
    Schneider MR; Ball H; Schönenberger H
    J Med Chem; 1985 Dec; 28(12):1880-5. PubMed ID: 4068009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Synthesis of diaryl-2- and -3-hexenes (author's transl)].
    Hamacher H; Brecht B
    Arch Pharm (Weinheim); 1977 Aug; 310(8):662-74. PubMed ID: 921502
    [No Abstract]   [Full Text] [Related]  

  • 8. Catechol estrogens of the 1,1,2-triphenylbut-1-ene type: relationship between structure, estradiol receptor affinity, estrogenic and antiestrogenic properties, and mammary tumor inhibiting activities.
    Schneider MR; Ball H; Schiller CD
    J Med Chem; 1986 Aug; 29(8):1355-62. PubMed ID: 3016262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platinum complexes with a selective action on estrogen receptor-positive mammary tumors.
    von Angerer E; Birnböck H; Knebel N
    Anticancer Drug Des; 1989 Jun; 4(1):21-35. PubMed ID: 2757751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia-selective antitumor agents. 5. Synthesis of water-soluble nitroaniline mustards with selective cytotoxicity for hypoxic mammalian cells.
    Palmer BD; Wilson WR; Cliffe S; Denny WA
    J Med Chem; 1992 Aug; 35(17):3214-22. PubMed ID: 1507207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oestrogenic and antioestrogenic actions in a series of triphenylbut-1-enes: modulation of prolactin synthesis in vitro.
    Jordan VC; Koch R; Mittal S; Schneider MR
    Br J Pharmacol; 1986 Jan; 87(1):217-23. PubMed ID: 3955300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxic esters of 1,1-bis-(4-hydroxyphenyl)-2-phenyl-but-1-ene with selective antitumor activity against estrogen receptor-containing mammary tumors.
    Schuderer ML; Schneider MR
    J Cancer Res Clin Oncol; 1987; 113(3):230-4. PubMed ID: 3584214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-(Hydroxyphenyl)indoles: a new class of mammary tumor inhibiting compounds.
    von Angerer E; Prekajac J
    J Med Chem; 1983 Jan; 26(1):113-6. PubMed ID: 6402593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-Phenylindole-linked [2-(aminoalkyl)pyridine]dichloroplatinum(II): complexes with a selective action on estrogen receptor positive mammary tumors.
    Knebel NG; von Angerer E
    J Med Chem; 1991 Jul; 34(7):2145-52. PubMed ID: 2066987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytostatic activity of an estradiol-linked nitrosourea in MXT mammary carcinoma and L 5222 leukemia.
    Zeller WJ; Schreiber J; Petru E; Eisenbrand G
    Arzneimittelforschung; 1989 Dec; 39(12):1577-9. PubMed ID: 2624608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel antitumor effect of estradiol in athymic mice injected with a T47D breast cancer cell line overexpressing protein kinase Calpha.
    Chisamore MJ; Ahmed Y; Bentrem DJ; Jordan VC; Tonetti DA
    Clin Cancer Res; 2001 Oct; 7(10):3156-65. PubMed ID: 11595710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and evaluation of B-, C-, and D-ring-substituted estradiol carboxylic acid esters as locally active estrogens.
    Labaree DC; Zhang JX; Harris HA; O'Connor C; Reynolds TY; Hochberg RB
    J Med Chem; 2003 May; 46(10):1886-904. PubMed ID: 12723952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ring-substituted 1,2-dialkylated 1,2-bis(hydroxyphenyl)ethanes. 2. Synthesis and estrogen receptor binding affinity of 4,4'-, 5,5'-, and 6,6'-disubstituted metahexestrols.
    Hartmann RW; Heindl A; Schönenberger H
    J Med Chem; 1984 May; 27(5):577-85. PubMed ID: 6325689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2-Phenylindoles. Effect of N-benzylation on estrogen receptor affinity, estrogenic properties, and mammary tumor inhibiting activity.
    von Angerer E; Strohmeier J
    J Med Chem; 1987 Jan; 30(1):131-6. PubMed ID: 3806590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benzo[a]carbazole derivatives. Synthesis, estrogen receptor binding affinities, and mammary tumor inhibiting activity.
    von Angerer E; Prekajac J
    J Med Chem; 1986 Mar; 29(3):380-6. PubMed ID: 3950918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.